We were pleased with Regeneron's performance to start 2026, highlighted by strong commercial execution across our key growth products, continued pipeline progress, a disciplined approach to capital ...
A numeric improvement of 5.1 months in median PFS was observed for the high-dose fianlimab combination compared to pembrolizumab monotherapy Phase 3 head-to-head trial of the high-dose fianlimab ...
Bayer Aktiengesellschaft ( BAYRY) Q1 2026 Earnings Call May 12, 2026 4:00 AM EDT Well, good morning, everybody, and welcome to our media update for the first quarter 2026. Many thanks for joining us ...
Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural ...
The trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS) A numeric improvement of 5.1 months in median PFS was observed for the high- ...
Share on Pinterest A new study identified several overlooked side effects of GLP-1 drugs through self-reporting among Reddit users. Image Credit: Fiordaliso/Getty Images A recent study found various ...
Ivermectin oral tablet is a generic medication used to treat intestinal strongyloidiasis and onchocerciasis affecting the eyes and skin. Common side effects include itching, diarrhea, nausea, ...
Creon (pancrelipase) is a prescription drug used to treat pancreatic insufficiency. Creon contains the active ingredient pancrelipase and comes as an oral delayed-release capsule. (This type of ...
Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...
April 29 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab beat Wall Street estimates for first-quarter revenue and profit on Wednesday, helped by strong demand for its eczema drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results